Zacks Investment Research
20 Nov 2025, 15:35 UTC · 50w ago
Down 16.9% in 4 Weeks, Here's Why Conmed (CNMD) Looks Ripe for a Turnaround
Impact · against what's priced in
The article presents a bullish technical and fundamental case for Conmed, highlighting an oversold RSI and upward earnings revisions. While the 16.9% recent price drop reflects negative momentum, the combined factors suggest a potential turnaround catalyst.
- CNMD+0.40
No priced-in read yet
- In context
The stock is technically oversold with an RSI of 29.21 and has seen a 0.6% increase in consensus EPS estimates over the last 30 days, suggesting a disconnect between current price momentum and fundamental trends.
Read from the article alone
Top 1 mover · tap to explore
